BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
James C. Barton, Pauline L. Lee. Disparate phenotypic expression of ALAS2 R452H (nt 1407 G → A) in two brothers, one with severe sideroblastic anemia and iron overload, hepatic cirrhosis, and hepatocellular carcinomaBlood Cells, Molecules, and Diseases 2006; 36(3): 342 doi: 10.1016/j.bcmd.2006.01.010
2
C. van Geffen, K. Savary-Bataille, K. Chiers, U. Giger, S. Daminet. Bilirubin cholelithiasis and haemosiderosis in an anaemic pyruvate kinase-deficient Somali catJournal of Small Animal Practice 2008; 49(9): 479 doi: 10.1111/j.1748-5827.2008.00568.x
3
Barbara Kohn, Christine Fumi. Clinical course of pyruvate kinase deficiency in Abyssinian and Somali catsJournal of Feline Medicine and Surgery 2008; 10(2): 145 doi: 10.1016/j.jfms.2007.09.006
4
J. Sripetchwandee, S. B. KenKnight, J. Sanit, S. Chattipakorn, N. Chattipakorn. Blockade of mitochondrial calcium uniporter prevents cardiac mitochondrial dysfunction caused by iron overloadActa Physiologica 2014; 210(2): 330 doi: 10.1111/apha.12162
5
Alberto Zanella, Elisa Fermo, Paola Bianchi, Laurent Roberto Chiarelli, Giovanna Valentini. Pyruvate kinase deficiency: The genotype-phenotype associationBlood Reviews 2007; 21(4): 217 doi: 10.1016/j.blre.2007.01.001
6
Maria Garcia-Gomez, Andrea Calabria, Maria Garcia-Bravo, Fabrizio Benedicenti, Penelope Kosinski, Sergio López-Manzaneda, Collin Hill, María del Mar Mañu-Pereira, Miguel A Martín, Israel Orman, Joan-LLuis Vives-Corrons, Charles Kung, Axel Schambach, Shengfang Jin, Juan A Bueren, Eugenio Montini, Susana Navarro, Jose C Segovia. Safe and Efficient Gene Therapy for Pyruvate Kinase DeficiencyMolecular Therapy 2016; 24(7): 1187 doi: 10.1038/mt.2016.87
7
Nicholas L. Rider, Kevin A. Strauss, Krysta Brown, Armin Finkenstedt, Erik G. Puffenberger, Christine L. Hendrickson, Donna L. Robinson, Nikolas Muenke, Chris Tselepis, Lauren Saunders, Heinz Zoller, D. Holmes Morton. Erythrocyte pyruvate kinase deficiency in an old-order Amish cohort: Longitudinal risk and disease managementAmerican Journal of Hematology 2011; 86(10): 827 doi: 10.1002/ajh.22118
8
Sam Vander Meeren, An Van Damme, Kristin Jochmans. Prominent basophilic stippling and hemochromatosis in glucose-6-phosphate dehydrogenase deficiencyInternational Journal of Hematology 2015; 101(2): 112 doi: 10.1007/s12185-014-1716-6
9
Nayna Riyat, Jinping Lai, Bruce Bacon. Hepatic Fibrosis as a Consequence of Iron Overload in Pyruvate Kinase DeficiencyAmerican Journal of Gastroenterology 2015; 110: S343 doi: 10.14309/00000434-201510001-00785
10
M. S. Salek, T. Ionova, J. R. Johns, E. N. Oliva. Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiencyQuality of Life Research 2019; 28(2): 399 doi: 10.1007/s11136-018-2025-y
11
Martine F. Raphaël, Richard Van Wijk, Joachim J. Schweizer, Netteke A.Y. Schouten-van Meeteren, Angelika Kindermann, Wouter W. van Solinge, Frans J. Smiers. Pyruvate kinase deficiency associated with severe liver dysfunction in the newbornAmerican Journal of Hematology 2007; 82(11): 1025 doi: 10.1002/ajh.20942